ID: ALA5170564
Chembl Id: CHEMBL5170564
PubChem CID: 163361724
Max Phase: Preclinical
Molecular Formula: C16H23N3O2
Molecular Weight: 289.38
Associated Items:
Canonical SMILES: CCCCc1ccc2nc(NC(=O)OC(C)CC)[nH]c2c1
Standard InChI: InChI=1S/C16H23N3O2/c1-4-6-7-12-8-9-13-14(10-12)18-15(17-13)19-16(20)21-11(3)5-2/h8-11H,4-7H2,1-3H3,(H2,17,18,19,20)
Standard InChI Key: PADMPXHAXGRANE-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 289.38 | Molecular Weight (Monoisotopic): 289.1790 | AlogP: 4.25 | #Rotatable Bonds: 6 |
| Polar Surface Area: 67.01 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 9.87 | CX Basic pKa: 4.46 | CX LogP: 4.94 | CX LogD: 4.94 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.83 | Np Likeness Score: -0.60 |
| 1. Liang D, Yu C, Ma Z, Hu M, Wang J, Dong X, Du L, Li M.. (2022) Design, synthesis and biological evaluation of new parbendazole derivatives for the treatment of HNSCC., 238 [PMID:35576703] [10.1016/j.ejmech.2022.114450] |
Source(1):
